Literature DB >> 15575868

Review article: the patient with gastro-oesophageal reflux disease--lifestyle advice and medication.

G Holtmann1, B Adam, T Liebregts.   

Abstract

Gastro-oesophageal reflux disease (GERD) is a highly prevalent disorder in all Western countries. Interestingly, prevalence rates appear to be increasing in these countries, with a remarkable increase of GERD-related lethal and nonlethal complications. However, these complications are rare on a global scale. This review aims to summarize the current concepts of genetic, lifestyle and environmental factors that need to be considered whilst caring for patients with these disorders. GERD is defined by the augmented exposure of oesophageal mucosa to acidic content, and is associated with specific symptoms or mucosal lesions. A number of factors may contribute to the manifestation of GERD. Although recent studies emphasize the role of genetic factors, there are many other risk factors that play a pivotal role in the development of GERD and GERD complications. Some nutritional factors are believed to aggravate acidic reflux either by delaying gastric emptying or diminishing the pressure of the lower oesophageal sphincters. Patients are often advised to sleep with their heads elevated, but this advice is not easy to follow and has not been proven effective with regard to long-term outcome. Other lifestyle modifications include changes to the patient's diet, which are important but not frequently sufficient. Thus, medication is usually necessary for symptom control. Proton pump inhibitors are now mainstream treatment for the reduction of acid secretion in patients with severe manifestations and 4-week healing rates are approaching 90%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15575868     DOI: 10.1111/j.1365-2036.2004.02224.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  Genetic factors in the pathogenesis of gastroesophageal reflux disease.

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  Indian J Gastroenterol       Date:  2011-05-12

2.  Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry.

Authors:  Dipti Chourasia; Asha Misra; Shweta Tripathi; Narendra Krishnani; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2011-01-26

3.  Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.

Authors:  Gerald Holtmann; Marc-André Bigard; Peter Malfertheiner; Roy Pounder
Journal:  Int J Clin Pharm       Date:  2011-04-07

4.  Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease.

Authors:  Takeshi Kamiya; Hiroshi Adachi; Makoto Hirako; Michiko Shikano; Eriko Matsuhisa; Tsuneya Wada; Naotaka Ogasawara; Shunsuke Nojiri; Hiromi Kataoka; Makoto Sasaki; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

5.  Lansoprazole for long-term maintenance therapy of erosive esophagitis: double-blind comparison with ranitidine.

Authors:  David A Peura; James W Freston; Marian M Haber; Thomas O Kovacs; Barbara Hunt; Stuart Atkinson
Journal:  Dig Dis Sci       Date:  2008-08-23       Impact factor: 3.199

6.  Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

7.  Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.

Authors:  Thomas O Kovacs; James W Freston; Marian M Haber; Barbara Hunt; Stuart Atkinson; David A Peura
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.